Rate My Professor Joanna Gullam

Dr Gullam's research specializations include maternal medicine and perinatal health, high-risk obstetrics, myometrial physiology and preterm birth, fetal growth restriction alongside placental function, the application of angiogenic biomarkers such as sFlt-1/PlGF in pregnancy complications, maternal immunisation strategies, neuroprotection, and participation in multicentre clinical trials focused on maternal-fetal health outcomes. As leader of the obstetric and perinatal research team, her work significantly influences evidence-based practices in perinatal care throughout Australasia. Key publications feature: Hughes, R.C.E. et al. (2025), 'In Suspected Fetal Growth Restriction, sFlt-1/PlGF and PlGF May Have Value in Risk Stratification' in the Australian & New Zealand Journal of Obstetrics & Gynaecology; Simões, E.A.F. et al. (2025), reporting on the efficacy of the MATISSE maternal RSV prefusion F vaccine in Obstetrics & Gynecology; Crowther, C.A. et al. (2023), the MAGENTA trial on prenatal magnesium sulphate in JAMA; and Tarnow-Mordi, W.O. et al. (2023) on perinatal trials in Seminars in Perinatology. She contributes to prominent trials including the Australian Placental Transfusion Study (APTS), Magnesium Sulphate at 30-34 weeks (MAGENTA), Sildenafil Therapy in Dismal Prognosis Early-Onset Intrauterine Growth Restriction (STRIDER NZAus), My Baby's Movements (MBM), Pre-diabetes Interventions and Nutrition Optimised Treatment (PINTO), MATISSE, C*STEROID, and PRECEDE. Furthermore, since 2020, she has been the RANZCOG Director of Fellowship Examinations and represents Aotearoa New Zealand on the International Saving Lives through Safer Birth steering committee.